IL149711A0 - Method for producing epinastine hydrochloride in the high-melting crystal modification - Google Patents

Method for producing epinastine hydrochloride in the high-melting crystal modification

Info

Publication number
IL149711A0
IL149711A0 IL14971100A IL14971100A IL149711A0 IL 149711 A0 IL149711 A0 IL 149711A0 IL 14971100 A IL14971100 A IL 14971100A IL 14971100 A IL14971100 A IL 14971100A IL 149711 A0 IL149711 A0 IL 149711A0
Authority
IL
Israel
Prior art keywords
crystal modification
epinastine hydrochloride
melting crystal
producing
producing epinastine
Prior art date
Application number
IL14971100A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of IL149711A0 publication Critical patent/IL149711A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL14971100A 1999-12-03 2000-11-29 Method for producing epinastine hydrochloride in the high-melting crystal modification IL149711A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19958460A DE19958460A1 (de) 1999-12-03 1999-12-03 Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
PCT/EP2000/011942 WO2001040229A2 (de) 1999-12-03 2000-11-29 Verfahren zur herstellung von epinastine-hydrochlorid in der hochschmelzenden kristallmodifikation

Publications (1)

Publication Number Publication Date
IL149711A0 true IL149711A0 (en) 2002-11-10

Family

ID=7931396

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14971100A IL149711A0 (en) 1999-12-03 2000-11-29 Method for producing epinastine hydrochloride in the high-melting crystal modification

Country Status (23)

Country Link
US (1) US6403790B1 (es)
EP (1) EP1237892B1 (es)
JP (1) JP4789383B2 (es)
KR (1) KR100737191B1 (es)
CN (1) CN1402728A (es)
AR (1) AR026678A1 (es)
AT (1) ATE238306T1 (es)
AU (1) AU2163501A (es)
BR (1) BR0016052A (es)
CA (1) CA2389170C (es)
CO (1) CO5251470A1 (es)
CZ (1) CZ20021843A3 (es)
DE (2) DE19958460A1 (es)
DK (1) DK1237892T3 (es)
EA (1) EA200200630A1 (es)
ES (1) ES2198368T3 (es)
HU (1) HUP0203501A2 (es)
IL (1) IL149711A0 (es)
MX (1) MXPA02005330A (es)
PL (1) PL355628A1 (es)
PT (1) PT1237892E (es)
UY (1) UY26461A1 (es)
WO (1) WO2001040229A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
JP4298212B2 (ja) * 2002-03-29 2009-07-15 大日本印刷株式会社 塩酸エピナスチン高融点型結晶の製造法
EP1531802A1 (en) * 2002-08-02 2005-05-25 Boehringer Ingelheim International GmbH Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
KR101386530B1 (ko) 2006-12-29 2014-04-18 케이피엑스 라이프사이언스 주식회사 순도 및 수율이 향상된3-아미노-9,13ｂ디하이드로-1Ｈ-디벤즈-[ｃ,ｆ]이미다조[1,5-ａ]-아제핀 염산염의 제조방법
CN104098575B (zh) * 2013-04-15 2016-06-01 四川科瑞德凯华制药有限公司 一种盐酸依匹斯汀晶型及其制备方法和用途
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
JP3726291B2 (ja) * 1993-07-05 2005-12-14 三菱ウェルファーマ株式会社 安定な結晶構造を有するベンゾオキサジン化合物およびその製造法
JPH083160A (ja) * 1994-06-22 1996-01-09 Nippon Kayaku Co Ltd ６−（１−ｈ−イミダゾール−１−イル）−７−ニトロ−２，３−（１ｈ，４ｈ）−キノキサリンジオン塩酸塩又は硫酸塩の分離精製法
JP3755908B2 (ja) * 1994-08-17 2006-03-15 塩野義製薬株式会社 セファロスポリン化合物の晶析法
JPH0948765A (ja) * 1995-08-04 1997-02-18 Toyama Chem Co Ltd 安定な結晶構造を有するトリアゾール誘導体およびその製造法
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne

Also Published As

Publication number Publication date
UY26461A1 (es) 2001-07-31
CO5251470A1 (es) 2003-02-28
KR20020058080A (ko) 2002-07-12
WO2001040229A2 (de) 2001-06-07
CZ20021843A3 (cs) 2002-08-14
WO2001040229A3 (de) 2001-12-06
ATE238306T1 (de) 2003-05-15
JP2003515536A (ja) 2003-05-07
DE50001920D1 (de) 2003-05-28
EA200200630A1 (ru) 2002-12-26
DK1237892T3 (da) 2003-08-04
EP1237892B1 (de) 2003-04-23
US6403790B1 (en) 2002-06-11
AU2163501A (en) 2001-06-12
EP1237892A2 (de) 2002-09-11
HUP0203501A2 (hu) 2003-03-28
AR026678A1 (es) 2003-02-19
PL355628A1 (en) 2004-05-04
DE19958460A1 (de) 2001-06-07
JP4789383B2 (ja) 2011-10-12
BR0016052A (pt) 2002-07-23
CN1402728A (zh) 2003-03-12
CA2389170A1 (en) 2001-06-07
KR100737191B1 (ko) 2007-07-10
ES2198368T3 (es) 2004-02-01
CA2389170C (en) 2008-01-08
PT1237892E (pt) 2003-08-29
MXPA02005330A (es) 2003-01-28

Similar Documents

Publication Publication Date Title
PT1293507E (pt) Processo para produção de cristais
EP1193333A4 (en) METHOD FOR PRODUCING SILICON CRYSTALS AND SILICON CRYSTAL
EP1216621A4 (en) SOFT SWEETS AND METHOD FOR THE PRODUCTION THEREOF
EP1125897A4 (en) SYNTHETIC SILICA GLASS AND PROCESS FOR PREPARING SAME
HK1041873A1 (en) Method for producing l-phenylephrine hydrochloride
EP1193332A4 (en) PROCESS FOR PRODUCING SILICON MONOCRYSTAL
HK1046443B (zh) 機械時計的日差調整方法
AU6537701A (en) Crystal modification
EP1076120A4 (en) METHOD FOR PRODUCING SILICON CRYSTALS
IL149711A0 (en) Method for producing epinastine hydrochloride in the high-melting crystal modification
GB9912828D0 (en) Spectacle frame
IL144264A0 (en) Process for producing quinolinecarbaldehyde
HUP0201508A3 (en) Granular water-dispersible agents and process for producing the same
GB2363379B (en) Process for producing alpha-aminoketones
HUP0002751A3 (en) Novel grignard-reagents and process for producing thereof
IL147804A0 (en) Method for producing 4-cyano-2-aminomethylthiazol
HUP0202109A2 (en) Method for producing 2-aminomethyl-4-cyano-thiazol
HUP0200455A3 (en) Method for producing 4-amino-5-chloro-1-phenyl pyridazinone-(6)
GB9905758D0 (en) Display set for spectacles
GB2353525B (en) Process for producing E-caprolactone
GB9910652D0 (en) Crystal vibrator
HU9903394D0 (en) Net-jewel and method for producing it
GB9918172D0 (en) Spectacle restraints
GB9915679D0 (en) Prescription goggles
PL334694A1 (en) Vibrating micro-conveyor